CAS: 199528-28-4 - 4'-TRIFLUOROMETHYL-BIPHENYL-3-CARBOXYLIC ACID
Formula:C14H8F3O2
InChI:InChI=1/C14H9F3O2/c15-14(16,17)12-6-4-9(5-7-12)10-2-1-3-11(8-10)13(18)19/h1-8H,(H,18,19)/p-1
- Synonyms:
- Akos Bar-0021
- 4'-(Trifluoromethyl)[1,1'-Biphenyl]-3-Carboxylic Acid
- Rarechem Al Be 1238
- 3-(4-(Trifluoromethyl)phenyl)benzoic acid
- 4'-Trifluoromethyl-biphenyl-7-carboxylic acid
- 4'-(Trifluoromethyl)Biphenyl-3-Carboxylate
[1,1'-Biphenyl]-3-carboxylic acid, 4'-(trifluoromethyl)-
CAS:199528-28-4
Formula:
C14H9F3O2
Purity:
97%
Color and Shape:
Solid
Molecular weight:
266.2153
Ref: IN-DA002C67
1g | 134.00 € | ||
100mg | 84.00 € | ||
250mg | 108.00 € | ||
500mg | 101.00 € |
Estimated delivery in United States, on Friday 13 Dec 2024
4'-Trifluoromethyl [1,1'-biphenyl]-3-carboxylic acid
CAS:199528-28-4
Formula:
C14H9F3O2
Purity:
By hplc: 97.9% (Typical Value in Batch COA)
Color and Shape:
white solid
Molecular weight:
266.22g/mol
Ref: 54-PC11183
100mg | 32.00 € | ||
250mg | 36.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
4'-(Trifluoromethyl)-3-biphenylcarboxylic Acid
CAS:199528-28-4
Applications 4'-(Trifluoromethyl)-3-biphenylcarboxylic Acid functions as a reagent in the scalable development of GPR40 receptor agonist …
Formula:
C14H9F3O2
Color and Shape:
Neat
Molecular weight:
266.215
Ref: TR-T779095
1g | 292.00 € | ||
250mg | 93.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
4'-TrifluoroMethyl-biphenyl-3-carboxylic acid
CAS:199528-28-4
Please enquire for more information about 4'-TrifluoroMethyl-biphenyl-3-carboxylic acid including the price, delivery time and more …
Purity:
Min. 95%
Ref: 3D-FT43951
1g | To inquire | ||
2g | To inquire | ||
5g | To inquire | ||
500mg | To inquire |
Estimated delivery in United States, on Friday 24 Jan 2025
4'-Trifluoromethylbiphenyl-3-carboxylic acid
CAS:199528-28-4
Purity:
95.0%
Color and Shape:
Solid
Molecular weight:
266.218994140625
Ref: 10-F014255
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
25g | Discontinued | Request information |